Skip to main content
. 2020 Jul 22;10(8):1087. doi: 10.3390/biom10081087

Figure 1.

Figure 1

Schematic representation of TAMs during anti-PD Abs monotherapy. TAMs in melanoma maintain immunosuppressive function through PD1/PD-L1 signals. Blockade of PD1/PD-L1 signaling activates CD163+ TAMs to inhibit tumor growth.